GrantsFeed
Grants & Funding

Czechia – Pharmaceutical products – Léčivé přípravky s účinnou látkou RAVULIZUMAB vs Decode the Immunoscience of age-related diseases

Side-by-side comparison of two grants.

AttributeCzechia – Pharmaceutical products – Léčivé přípravky s účinnou látkou RAVULIZUMABDecode the Immunoscience of age-related diseases
TypeTenderGrant
Funding amount$16.6M$10.7M
DeadlineCloses 2026-10-23Closes 2026-10-08
RegionCZEEU
SectorHealthHealth
FunderFakultní nemocnice BrnoEuropean Commission (HORIZON)
Who it's forindividuals, researchers

noindex — no measured search demand